Zobrazeno 1 - 10
of 39
pro vyhledávání: '"B.A. Hynd"'
Publikováno v:
Journal of Lipid Research, Vol 22, Iss 5, Pp 800-810 (1981)
A specific, accurate, and sensitive double antibody radioimmunoassay for measuring human apolipoprotein (apo) C-III has been developed. Anti-apoC-III(1) developed in rabbits cross-reacted completely with apoC-III subspecies. Analytical isoelectric fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cda1beb2cb5a92efddd11c96829af77a
https://doi.org/10.1016/s0022-2275(20)37352-1
https://doi.org/10.1016/s0022-2275(20)37352-1
Publikováno v:
Biochemical and Biophysical Research Communications. 121:946-952
Lipolysis of human very low density lipoproteins (VLDL) by lipoprotein lipase (LPL) was inhibited in the presence of high density lipoproteins (HDL), anti-apolipoprotein (apo) CII, and by increasing the VLDL free cholesterol content but not with anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b02599b1a731e0be30fe2a3153be4190
https://doi.org/10.1016/0006-291x(84)90768-x
https://doi.org/10.1016/0006-291x(84)90768-x
Autor:
Moti L. Kashyap, P.J. Kinnunen, K. Robinson, Timo Kuusi, C.J. Glueck, Marja-Riitta Taskinen, L.S. Srivastava, G. Perisutti, B.A. Hynd
Publikováno v:
Atherosclerosis. 37:247-256
Post-heparin lipoprotein lipase (PH-LPL)-high density lipoprotein cholesterol (HDL-C) interrelationships were assessed in 9 subjects with documented familial hyperalphalipoproteinemia (FHA) and in 8 controls to focus on potential biochemical etiologi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce533ae55617bafd278a7b59c358ae06
https://doi.org/10.1016/0021-9150(80)90010-6
https://doi.org/10.1016/0021-9150(80)90010-6
Publikováno v:
Metabolism. 33:432-438
Recent studies show that the normal and diseased kidney is an important organ in the catabolism of high-density lipoproteins (HDL). However, little is known about the renal handling of HDL. To investigate this aspect, kidneys were isolated from norma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d97be5537a69deda151e2a6f98bbc4ed
https://doi.org/10.1016/0026-0495(84)90143-4
https://doi.org/10.1016/0026-0495(84)90143-4
Publikováno v:
Journal of Lipid Research, Vol 21, Iss 4, Pp 491-495 (1980)
Scopus-Elsevier
Scopus-Elsevier
When total protein in very low density lipoprotein samples is measured by the method of Lowry et al. (1951. J. Biol. Chem 193:265-275), turbidity remains in the final color reaction. Addition of 0.1 ml of 2.5% (v/v) solution of Triton X-100 removes t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b60663bdc6d1c1f5a7b55ea293a7906a
http://www.sciencedirect.com/science/article/pii/S0022227520398035
http://www.sciencedirect.com/science/article/pii/S0022227520398035
Publikováno v:
Metabolism. 34:30-35
Very low-density lipoproteins (VLDL) contain sialylated apolipoproteins (apo) (eg, apo CIII1–3) that inhibit apo CII activation of lipoprotein lipase (LPL) and also uptake of triglyceride (TG)-rich lipoproteins by the liver. Hypertriglyceridemic pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fd07f0339f4f4d55ea20bbbe497617c
https://doi.org/10.1016/0026-0495(85)90056-3
https://doi.org/10.1016/0026-0495(85)90056-3
Autor:
B.A. Hynd, Peter S. Gartside, Moti L. Kashyap, Michael Laver, Soaira G. Mendoza, Keijiro Saku
Publikováno v:
Nephron. 50:112-115
The kinetic parameters of high-density lipoprotein (HDL) and its major apolipoproteins (Apo) AI and Apo AII were studied in 2 patients with moderate and severe proteinuria and 2 normal controls after intravenous injection of autologous 125I-HDL. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f54fc993d8343f3eccf54ce0c90c2a12
https://doi.org/10.1159/000185139
https://doi.org/10.1159/000185139
Autor:
B.A. Hynd, L S Srivastava, Keijiro Saku, Bruce McDonald, Moti L. Kashyap, Carmelo Cedres, Bing W. Liu
Publikováno v:
The American Journal of Medicine. 77:457-462
A new case of C-II anapolipoproteinemia (complete apolipoprotein C-II deficiency) as the cause of severe hypertriglyceridemia with chylomicronemia (type I lipoprotein phenotype) is described. The patient was a five-year-old boy living in Connecticut.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a5aae344399cc7444f54eb2e7d2e295
https://doi.org/10.1016/0002-9343(84)90102-5
https://doi.org/10.1016/0002-9343(84)90102-5
Publikováno v:
Biochemical medicine. 25(3)
Serum and urinary cholesterol, triglycerides, high-density lipoproteins, and tissue lipoprotein lipase levels were measured in a group of rats in which experimental glomerulonephritis (EGN) was induced by an injection of renal tubular antigen in Freu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92064b90725ed6b6ad6497ed2bf6f826
https://pubmed.ncbi.nlm.nih.gov/7271761
https://pubmed.ncbi.nlm.nih.gov/7271761
Publikováno v:
The Journal of clinical investigation. 75(5)
Gemfibrozil is a potent lipid regulating drug whose major effects are to increase plasma high density lipoproteins (HDL) and to decrease plasma triglycerides (TG) in a wide variety of primary and secondary dyslipoproteinemias. Its mechanism of action
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7227d9d30620b24a0981718d5b3b2c7f
https://pubmed.ncbi.nlm.nih.gov/3923042
https://pubmed.ncbi.nlm.nih.gov/3923042